Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Twist Bioscience Corp shares valued at $69,160 were sold by Finn Patrick John on Oct 23 ’25. At $30.88 per share, Finn Patrick John sold 2,240 shares. The insider’s holdings dropped to 206,495 shares worth approximately $6.65 million following the completion of this transaction.
Also, Finn Patrick John purchased 2,240 shares, netting a total of over 69,160 in proceeds.
Before that, Laponis Adam had sold 3,000 shares from its account. In a trade valued at $93,450, the Chief Financial Officer traded Twist Bioscience Corp shares for $31.15 each. Upon closing the transaction, the insider’s holdings decreased to 3,000 shares, worth approximately $3.03 million.
As published in their initiating research note from Wolfe Research on December 13, 2024, Twist Bioscience Corp [TWST] has been an Outperform and the price target has been revised to $60. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 17, 2024, Goldman has increased its “Neutral” rating to a “Buy” for TWST. Earlier on September 27, 2023, Berenberg initiated its rating. Their recommendation was “a Buy” for TWST stock.
Analyzing TWST Stock Performance
On last trading session, Twist Bioscience Corp [NASDAQ: TWST] plunged -4.05% to $32.21. The stock’s lowest price that day was $31.94, but it reached a high of $34.0 in the same session. During the last five days, there has been a surge of approximately 3.70%. Over the course of the year, Twist Bioscience Corp shares have dropped approximately -20.67%. Shares of the company reached a 52-week high of $55.33 on 01/24/25 and a 52-week low of $24.07 on 09/10/25.
Support And Resistance Levels for Twist Bioscience Corp (TWST)
According to the 24-hour chart, there is a support level at 31.43, which, if violated, would cause prices to drop to 30.66. In the upper region, resistance lies at 33.49. The next price resistance is at 34.78. RSI (Relative Strength Index) is 53.88 on the 14-day chart, showing neutral technical sentiment.
Is Twist Bioscience Corp subject to short interest?
Stocks of Twist Bioscience Corp saw a sharp steep in short interest on 2025-10-15 dropping by -1.96 million shares to 10.86 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 12.82 million shares. A decline of -18.01% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.96 of the overall float, the days-to-cover ratio (short ratio) decline to 5.96.
Which companies own the most shares of Twist Bioscience Corp (TWST)?
In terms of Twist Bioscience Corp share price expectations, FactSet research, analysts set an average price target of 44 in the next 12 months, up nearly 31.07% from the previous closing price of $33.57. Analysts anticipate Twist Bioscience Corp stock to reach 46 by 2025, with the lowest price target being 40. In spite of this, 7 analysts ranked Twist Bioscience Corp stock as Buy at the end of 2025. On January 05, 2023, Scotiabank assigned a price target of “a Sector outperform” to the stock and initiated coverage with a $33.
